Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study

Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study

Abstract Background Data are limited on the association of metabolic dysfunction-associated fatty liver disease (MAFLD) with systemic atherosclerosis. This study aimed to examine the relationship between MAFLD and the extent of atherosclerotic plaques and stenosis, and presence of polyvascular disea...

Full description

Bibliographic Details
Main Authors:	Yanli Zhang, Zhang Xia, Xueli Cai, Xin Su, Aoming Jin, Lerong Mei, Jing Jing, Suying Wang, Xia Meng, Shan Li, Mengxing Wang, Tiemin Wei, Yongjun Wang, Yan He, Yuesong Pan
Format:	Article
Language:	English
Published:	BMC 2023-12-01
Series:	Cardiovascular Diabetology
Subjects:	Fatty liver disease Metabolic dysfunction Atherosclerosis Polyvascular disease Diabetes mellitus
Online Access:	https://doi.org/10.1186/s12933-023-02083-0

Similar Items

Patient with Polyvascular Atherosclerosis Acutely Complicated with Different Major Vascular Events
by: O. Koval, et al.
Published: (2020-02-01)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels
by: Sayaka Funabashi, et al.
Published: (2022-08-01)

Association between triglyceride glucose index and atherosclerotic plaques and Burden: findings from a community-based study
by: Mengxing Wang, et al.
Published: (2022-10-01)

Associations Between Polyvascular Disease and Stroke Recurrence in Patients With Lacunar Stroke
by: Lin Ma, et al.
Published: (2021-09-01)

Association of Polyvascular Disease and Elevated Interleukin-6 With Outcomes in Acute Ischemic Stroke or Transient Ischemic Attack
by: Ye Tian, et al.
Published: (2021-04-01)

Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement
by: Előd Ernő Nagy, et al.
Published: (2022-03-01)

CYP2C19 &ast;2/&ast;2 Genotype is a Risk Factor for Multi-Site Arteriosclerosis: A Hospital-Based Cohort Study
by: Xie J, et al.
Published: (2023-11-01)

Higher visceral adiposity index and lipid accumulation product in relation to increased risk of atherosclerotic burden in community-dwelling older adults
by: Jingping Sun, et al.
Published: (2023-04-01)

Risk Factors for Polyvascular Involvement in Patients With Peripheral Artery Disease: A Mendelian Randomization Study
by: Ozan Dikilitas, et al.
Published: (2020-12-01)

Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
by: Congxiang Shao, et al.
Published: (2023-01-01)

Prognostic Role of Polyvascular Involvement in Patients with Symptomatic Peripheral Artery Disease
by: Luise Adam, et al.
Published: (2023-05-01)

Association of insulin resistance with intra- and extra-cranial atherosclerotic burden in the nondiabetic community population
by: Xueli Cai, et al.
Published: (2023-10-01)

Associations of deep medullary veins with vascular risk factors, laboratory indicators, and cerebral small vessel disease: A population‐based study
by: Yu Tian, et al.
Published: (2023-05-01)

Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease
by: Michael Szarek, et al.
Published: (2022-06-01)

Carotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation
by: Giusy Sirico, et al.
Published: (2016-01-01)

The prognostic value of peripheral arteries diseases in patients with ST-segment elevation myocardial infarction
by: M. V. Zykov, et al.
Published: (2012-06-01)

Effect of vascular burden as measured by vascular indexes upon vascular dementia: a matched case-control study
by: Takahashi PY, et al.
Published: (2012-01-01)

Serum Pentosidine is Associated with Cardiac Dysfunction and Atherosclerosis in T2DM
by: Cao Y, et al.
Published: (2023-01-01)

Updated Role of Neuropeptide Y in Nicotine-Induced Endothelial Dysfunction and Atherosclerosis
by: Yan-li Zheng, et al.
Published: (2021-02-01)

Blood Pressure Partially Mediated the Association of Insulin Resistance and Cerebral Small Vessel Disease: A Community‐Based Study
by: Mengyuan Zhou, et al.
Published: (2024-03-01)

Association of inflammatory markers with cerebral small vessel disease in community-based population
by: Lingling Jiang, et al.
Published: (2022-05-01)

Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options
by: V. G. Grachev, et al.
Published: (2021-05-01)

Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 1: Risk Stratification and Diagnosis
by: V. G. Grachev, et al.
Published: (2021-03-01)

Increase in high-sensitive C-reactive protein as a marker of polyvascular disease in patients with cardiovascular diseases
by: V. V. Genkel, et al.
Published: (2019-10-01)

Risk of subclinical atherosclerosis across metabolic transition in individuals with or without fatty liver disease: a prospective cohort study
by: Zhuojun Xin, et al.
Published: (2023-03-01)

Vascular dysfunction and atherosclerosis in chronic kidney disease; A distinct entity
by: Eranga Harshani Silva, et al.
Published: (2019-04-01)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
by: Giulia Magnani, et al.
Published: (2023-08-01)

Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases
by: Yongjun Wang, et al.

Association between Life’s Essential 8 and Cerebral Small Vessel Disease
by: Yongjun Wang, et al.

ENDOTHELIAL DYSFUNCTION – A KEY FACTOR IN ATHEROSCLEROSIS PATHOGENESIS
by: E. N. Vorobyeva, et al.
Published: (2010-04-01)

Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
by: Mohammad Alkhalil, et al.
Published: (2021-03-01)

Vitamin D and atherosclerosis
by: Vesna Lazić, et al.
Published: (2021-06-01)

Fatty-Acid-Binding Protein 4 as a Novel Contributor to Mononuclear Cell Activation and Endothelial Cell Dysfunction in Atherosclerosis
by: Yen-Wen Wu, et al.
Published: (2020-12-01)

Dyslipidemia and peripheral arterial disease
by: Ajay Yadav, et al.
Published: (2024-03-01)

Role of endothelial dysfunction in pathogenesis of atherosclerosis
by: Yu. P. Nikitin, et al.
Published: (2011-06-01)

Role of serum Irisin in Early Detection of Subclinical Atherosclerosis and Endothelial Dysfunction in Patients with Behcet's Disease
by: Ola Mounir*, et al.
Published: (2023-07-01)

Association between diabetes duration and 1‐year prognosis of stroke: A national registry study
by: Yanli Zhang, et al.
Published: (2022-09-01)

Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study
by: Yongjun Wang, et al.

Autophagy and Mitophagy as Essential Components of Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2021-02-01)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
by: Fang Lei, et al.
Published: (2023-04-01)